Answers are grounded in this paper and cite their sources.
Findings reveal higher mortality rates in patients with CKM syndrome and metabolic dysfunction-associated liver disease, indicating serious health implications.
The majority of MASLD patients also have CKM syndrome. A significant increase in all-cause and cardiovascular mortality is associated with advancing CKM stages.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: